Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
The FDA wants your input on how to regulate generative AI in medical devices. The agency released a discussion paper proposing a "competency-based approach" — modeled after how human clinicians are trained and credentialed — to evaluate AI-equipped devices in real-world clinical scenarios. Public feedback is due by October 19.
The FDA is taking a page from medical education to figure out how to regulate AI-powered medical devices. The agency released a discussion paper outlining a "competency-based approach" for evaluating generative AI-enabled devices — inspired by how human clinicians are trained, tested, and credentialed before practicing independently.
The proposed framework has two phases: nonclinical benchmarking (assessing safety, clinical proficiency, and generalizability — potentially using synthetic data or virtual patient avatars) and clinical confirmation (testing performance under real-world conditions via prospective studies, shadow deployments, or clinician review of actual patient-device interactions). The FDA is also weighing whether to accept more premarket uncertainty in exchange for stronger postmarket monitoring.
Key Takeaways:
Why it matters: As AI tools rapidly enter clinical workflows, clear regulatory guardrails are urgently needed. This framework could shape how AI medical devices are approved and monitored globally — making early public input especially consequential.
